Metabolomic tissue signature in human non-alcoholic fatty liver disease identifies protective candidate metabolites.
von Schönfels W, Patsenker E, Fahrner R, Itzel T, Hinrichsen H, Brosch M, Erhart W, Gruodyte A, Vollnberg B, Richter K, Landrock A, Schreiber S, Brückner S, Beldi G, Sipos B, Becker T, Röcken C, Teufel A, Stickel F, Schafmayer C, Hampe J.
von Schönfels W, et al.
Liver Int. 2015 Jan;35(1):207-14. doi: 10.1111/liv.12476. Epub 2014 Mar 6.
Liver Int. 2015.
PMID: 24484068
Small-molecule metabolite screens may offer new insights into disease mechanisms and reveal new treatment targets. METHODS: Discovery (N = 33) and replication (N = 66) of liver biopsies spanning the range from normal liver histology to non-alcoholic steatohepatitis …
Small-molecule metabolite screens may offer new insights into disease mechanisms and reveal new treatment targets. METHODS: Discovery (N …